hometown security laboratories for enhancements in quality of life and community stability, inc.

attn: jeffrey s. lowenthal
180 maiden lane
new york, new york 10038

NYS Entity Status
ACTIVE

NYS Filing Date
JANUARY 09, 2013

NYS DOS ID#
4343121

County
BRONX

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION

Name History
2013 - HOMETOWN SECURITY LABORATORIES FOR ENHANCEMENTS IN QUALITY OF LIFE AND COMMUNITY STABILITY, INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Five Sites of New York’s L.G.B.T. History
    Monday Jun 19, 2017

    Jacob Riis Park, a Manhattan church, the Bum Bum Bar and more. In 360 degrees, visit five sites that helped shape New York City’s L.G.B.T. community and its history.

    Source: NYT > Home Page
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy New York
  • Living the Urban Life Upstate
    By KIM VELSEY - Friday Jun 16, 2017

    A New York couple who prefer to rent in the thick of things, even in a Hudson Valley town.

    Source: NYT > Home Page
  • Food & Wine Magazine Will Leave New York for Alabama
    By STEPHANIE STROM - Friday Jun 23, 2017

    The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.

    Source: NYT > Home Page
  • In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions
    By Alex Lash - Wednesday May 31, 2017

    Has the era of genetic oncology arrived? Last week, the biomedical world took a notable step in that direction when the FDA said Merck’s drug pembrolizumab (Keytruda), already one of the world’s most successful cancer immunotherapies, could now treat any tumor with a particular genetic fingerprint. It was the first time a drug has been […]

    Source: Xconomy New York
  • 'NY Times' Finally Joins Snapchat Discover
    Monday Apr 24, 2017

    Does The New York Times joining Snapchat Discover lend an air of respectability to a new platform, and breathe new life into an aging publisher? That's obviously what the partners are planning -- butonly time will tell.

    Source: Media Post: MoBlog
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy VC, Deals, & Startups Feed
  • The Times Sharply Increases Articles Open for Comments, Using Google’s Technology
    By BASSEY ETIM - Tuesday Jun 13, 2017

    A new comments system at The New York Times will allow the community desk to moderate more reader comments than ever before.

    Source: NYT > Home Page